Dr. Felix Cabrera has been hired as the Department of Public Health’s chief medical officer. KUAM reported on Friday afternoon that Dr. Cabrera was hired on a two year employment contract for $2
New daily confirmed COVID-19 cases in America have risen sharply in the past few weeks, taking counts to record levels. For several days in the past month, new confirmed cases have risen above 250,000 a day. Yesterday, according to the Microsoft Bing COVID-19 Tracker, cases rose by 283,322 to 22,049,452. The next three months will […]
mRNA vaccines could vanquish covid-19 today, cancer tomorrow
Premium
FILE - In this Tuesday, Dec. 1, 2020 file photo, a worker shows how dry ice is used on specific vaccines and medicines to keep them cool during a demonstration of logistics and handling of vaccines and medicines at a cargo warehouse in Steenokkerzeel, Belgium. On Friday, Dec. 4, 2020, The Associated Press reported on stories circulating online incorrectly asserting that a vaccine that needs to be shipped and stored at -80 degrees “isn’t a vaccine” but a “transfection agent” that will infect your cells and transfer genetic material causing “genetic manipulation.” According to Deborah Fuller, a professor of microbiology at the University of Washington School of Medicine, “mRNA vaccines can’t integrate into the human genome so there is no possibility of genetic manipulation of humans. mRNA vaccines deliver their code to the cell and once the cell translates that into a vaccine, the mRNA vaccine is d
Obesity is big business and as a result, so are bariatric surgeries. They are a popular fail safe for people who believe they lack the mental resolve to eat less but is it really the most cost effective way to treat obesity now that health care is government controlled?
Writing in both
BMJ and
JAMA, David Arterburn, MD, MPH, weighs the evidence on the benefits and risks of the various types of this surgery. It s critical that we find effective and cost-effective ways to treat severe obesity, said Dr. Arterburn, an associate investigator at Group Health Research Institute, a Group Health physician, and an affiliate associate professor of medicine at the University of Washington School of Medicine.
India could get nasal vaccine against Covid-19 soon, trials set to begin in Nagpur
India could get nasal vaccine against Covid-19 soon, trials set to begin in Nagpur
Bharat Biotech, whose Covaxin vaccine has already received emergency use approval, has said that the trial of a nasal variant of Covid-19 vaccine could begin in Nagpur in the next two weeks. Bharat Biotech to submit a proposal to DCGI soon.
advertisement
(Representational image. Photo: AFP)
A nasal Covid-19 vaccine could be a reality in India soon with Bharat Biotech, the Indian vaccine maker, all set to start phase 1 and 2 trials of a nasal vaccine at Gillurkar Multi Speciality Hospital in Nagpur.